Design and synthesis of novel, pseudo C2 symmetric inhibitors of HIV protease

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 18, 1996, Pages 2201-2206

  Hanessian, Stephen ^a   Devasthale, Pratik V ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; REACTION ANALYSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030591704     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00392-7     Document Type: Article

References (38)

1. 1. (a) Huff, J. R. J. Med. Chem. 1991, 34, 2305.
2. (b) Thaisrivongs, S. Chapter 14. Annu. Rep. Med. Chem. 1994, 29, 133.
3. (c) Tomasselli, A. G.; Howe, W. J.; Sawyer, T. K.; Wlodawer, A.; Heinrikson, R. L. Chim. Oggi 1991, 9, 6.
4. (d) Wlodawer, A.; Erickson, J. W. Annu. Rev. Biochem. 1993, 62, 543.
5. (e) Clare, M. Perspect. Drug Discovery Des. 1993, 1, 49.
6. (f) Meek, T. D. J. Enzyme Inhib. 1992, 6, 65.
7. (g) Norbeck, D. W.; Kempf, D. J. Annu. Rep. Med. Chem. 1991, 26, 141.
8. (h) Lang, M.; Roesel, J. Arch. Pharm. (Weinheim, Ger) 1993, 326, 921.
9. (i) Darke, P, L.; Huff, J. R. In Advances in Pharmacology; August, J. T.; Anders, M. W.; Murad, F., Eds.; Academic: San Diego, 1994; vol 25, pp 399.
10. (j) Martin, J. A. Antiviral Res. 1992, 17, 265.
11. (k) Debouck, C. AIDS Res. Human Retroviruses 1992, 8, 153.
12. 2. Kohl, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A.; Scolnick, E. M.; Sigal, I. Proc. Nat. Acad. Sci. USA. 1988, 85, 4686.
13. 3. (a) Kempf, D. J.; Norbeck, D. W.; Codacovi, L.; Wang, X. C.; Kohlbrenner, W. E.; Wideburg, N.; Paul, D. A.; Knigge, M. F.; Vasavanonda, S.; Craig-Kennard, A.; Saldivar, A.; Rosenbrook, W, Jr.; Clement, J. J.; Plattner, J. J.; Erickson, J. J. Med. Chem. 1990, 33, 2687.
14. (b) Barrish, J. C.; Gordon, E.; Alam, M.; Lin, P.-F.; Bisacchi, G. S.; Chen, P.; Cheng, P. T. W.; Fritz, A. W.; Greytok, J. A.; Hermsmeier, M. A.; Humphreys, W. G.; Lis, K. A.; Marella, M. A.; Merchant, Z.; Mitt, T.; Morrison, R. A.; Obermeier, M. T.; Pluscec, J.; Skoog, M.; Slusarchyk, W. A.; Spergel, S. H.; Stevenson, J. M.; Sun, C-q.; Sundeen, J. E.; Taunk, P.; Tino, J. A.; Warrack, B. M.; Colonno, R. J.; Zahler, R. J. Med. Chem. 1994, 37, 1758.
15. (c) Ettmayer, P.; Hübner, M.; Billich, A.; Rosenwirth, B.; Gstach, H. Bioorg. Med. Chem. Lett. 1994, 4, 2851.
16. (d) Bone, R.; Vacca, J. P.; Anderson, P. S.; Holloway, M. K. J. Am. Chem. Soc. 1991, 113, 9382; Babine, R. E.; Zhang, N.; Jurgens, A. R.; Schow, S. R.; Desai, P. R.; James, J. C.; Semmelhack, M. F. Bioorg. Med. Chem. Lett. 1992, 2, 541.
17. (d) Bone, R.; Vacca, J. P.; Anderson, P. S.; Holloway, M. K. J. Am. Chem. Soc. 1991, 113, 9382; Babine, R. E.; Zhang, N.; Jurgens, A. R.; Schow, S. R.; Desai, P. R.; James, J. C.; Semmelhack, M. F. Bioorg. Med. Chem. Lett. 1992, 2, 541.
18. (e) Erickson, J.; Neidhart, D. J.; VanDrie, J.; Kempf, D. J.; Wang, X. C.; Norbeck, D. W.; Plattner, J. J.; Rittenhouse, J. W.; Turon, M.; Wideburg, N.; Kohlbrenner, W. E.; Simmer, R.; Helfrich, R.; Paul. D. A.; Knigge, M. Science 1990, 249, 527.
19. 4. Hanessian, S.; Devasthale, P. V. Tetrahedron Lett. 1996, 7, 987.
20. 5. Reetz, M. T. Angew. Chem. Int. Ed. Engl. 1991, 30, 1531.
21. 6. For another example, see: Sasai, H.; Kim, W-S.; Suzuki, T.; Shibasaki, M. Tetrahedron Lett. 1994, 35, 6123.
22. 13C NMR, MS, IR, CHN analysis or HRMS.
23. 8. Sinhababu, A.; Borchardt, R. T. Tetrahedron Lett. 1983, 24, 227.
24. 9. Ballini, R.; Palestini, C. Tetrahedron Lett. 1994, 35, 5731.
25. 10. (a) Meienhofer, J. In The Peptides, Gross, E.; Meienhofer, J., Eds.; Academic: New York, 1979; vol. 1, pp 263.
26. (b) Chenera, B.; Boehm, J. C.; Dreyer, G. B. Bioorg. Med. Chem. Lett. 1991, 1, 219.
27. 11. Aebischer, B.; Bieri, J. H.; Prewo, R.; Vasella, A. Helv. Chim. Acta 1982, 65, 2251.
28. 12. ElAmin, B.; Ananthramaiah, G. M.; Royer, G. P.; Means, G. E. J. Org. Chem. 1979, 44, 3442.
29. -1 suggesting that γ-(and not ε) lactamization had taken place. For recent examples of γ-lactamization accompanying reduction of nitro groups, see (a) Nyerges, M.; Bitter, I.; Kádas, I.; Tóth, G.; Toke, L. Tetrahedron Lett. 1994, 35, 4413.
30. (b) Chittari, P.; Thomas, A.; Rajappa, S. Tetrahedron Lett. 1994, 35, 3793.
31. 14. Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
32. 15. Ono, N.; Fujii, M.; Kaji, A. Synthesis 1987, 532.
33. 16. Reetz, M. T.; Drewes, M. W.; Mathews, B, R.; Lennick, K. J. Chem. Soc. Chem. Commun. 1989, 1474.
34. 17. Morelock, M. M.; Pargellis, C. A.; Graham, E. T.; Lamarre, D.; Jung, G. J. Med. Chem. 1995, 38, 1751.
35. 18. Kempf, D. J.; Marsh, K. C.; Paul, D. A; Knigge, M. F.; Norbeck, D. W.; Kohlbrenner, W. E.; Codacovi, L.; Vasavanonda, S.; Bryant, P.; Wang, X. C.; Wideburg, N. E.; Clement, J. J.; Plattner, J. J.; Erickson, J. Antimicrob. Agents Chemother. 1991, 35, 2209; see also: Kempf, D. J.; Marsh, K. C.; Fino, L. C.; Bryant, P.; Craig-Kennard, A.; Sham, H. L.; Zhao, C.; Vasavanonda, S.; Kohlbrenner, W. E.; Wideburg, N. E.; Saldivar, A.; Green, B. E.; Herrin, T.; Norbeck, D. W. Bioorg. Med. Chem. 1994, 2, 847.
36. 18. Kempf, D. J.; Marsh, K. C.; Paul, D. A; Knigge, M. F.; Norbeck, D. W.; Kohlbrenner, W. E.; Codacovi, L.; Vasavanonda, S.; Bryant, P.; Wang, X. C.; Wideburg, N. E.; Clement, J. J.; Plattner, J. J.; Erickson, J. Antimicrob. Agents Chemother. 1991, 35, 2209; see also: Kempf, D. J.; Marsh, K. C.; Fino, L. C.; Bryant, P.; Craig-Kennard, A.; Sham, H. L.; Zhao, C.; Vasavanonda, S.; Kohlbrenner, W. E.; Wideburg, N. E.; Saldivar, A.; Green, B. E.; Herrin, T.; Norbeck, D. W. Bioorg. Med. Chem. 1994, 2, 847.
37. 19. Randad, R. S.; Lubkowska, L.; Bujacz, A., Naik, R. H.; Gulnik, S. V.; Yu, B.; Silva, A.; Munshi, S.; Lynch, T. M.; Clanton, D. J.; Bhat, T. N.; Erickson, J. W. Bioorg. Med. Chem. Lett. 1995, 5, 2557.
38. 20. Hanessian, S.; Kagolani, M.; Koumaglo, K. Heterocycles 1989, 28, 1115.